Marketa Skala

1.3k total citations
23 papers, 392 citations indexed

About

Marketa Skala is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Oncology. According to data from OpenAlex, Marketa Skala has authored 23 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiation and 5 papers in Oncology. Recurrent topics in Marketa Skala's work include Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (13 papers) and Advanced Radiotherapy Techniques (8 papers). Marketa Skala is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (13 papers) and Advanced Radiotherapy Techniques (8 papers). Marketa Skala collaborates with scholars based in Australia, New Zealand and Canada. Marketa Skala's co-authors include Andrew Kneebone, David Pryor, David Christie, Margot Lehman, Amy Hayden, George Hruby, Sandra Turner, Jeremy Millar, Mark Sidhom and Adele F. Holloway and has published in prestigious journals such as Scientific Reports, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Marketa Skala

23 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marketa Skala Australia	13	278	158	96	62	54	23	392
Anjali Zarkar United Kingdom	9	202 0.7×	100 0.6×	66 0.7×	87 1.4×	64 1.2×	26	319
Matteo Muto Italy	11	208 0.7×	78 0.5×	90 0.9×	47 0.8×	61 1.1×	30	330
Emile N. van Lin Netherlands	10	360 1.3×	219 1.4×	173 1.8×	71 1.1×	59 1.1×	11	487
A.C.M. van den Bergh Netherlands	9	152 0.5×	70 0.4×	107 1.1×	112 1.8×	22 0.4×	19	400
Carol Fraser‐Browne New Zealand	8	321 1.2×	118 0.7×	50 0.5×	56 0.9×	38 0.7×	13	380
Eva E. Schaake Netherlands	12	208 0.7×	61 0.4×	117 1.2×	59 1.0×	91 1.7×	26	317
Nirdosh Kumar Gogna Australia	11	297 1.1×	116 0.7×	99 1.0×	112 1.8×	104 1.9×	13	430
Wesley W. Choi United States	8	299 1.1×	70 0.4×	59 0.6×	91 1.5×	71 1.3×	11	435
M. Santoro United States	7	356 1.3×	279 1.8×	45 0.5×	67 1.1×	45 0.8×	13	434
Joseph P. Rodgers United States	10	163 0.6×	69 0.4×	30 0.3×	118 1.9×	53 1.0×	30	338

Countries citing papers authored by Marketa Skala

Since Specialization

Citations

This map shows the geographic impact of Marketa Skala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marketa Skala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marketa Skala more than expected).

Fields of papers citing papers by Marketa Skala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marketa Skala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marketa Skala. The network helps show where Marketa Skala may publish in the future.

Co-authorship network of co-authors of Marketa Skala

This figure shows the co-authorship network connecting the top 25 collaborators of Marketa Skala. A scholar is included among the top collaborators of Marketa Skala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marketa Skala. Marketa Skala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marthick, James R., Leigh Blizzard, Chol‐Hee Jung, et al.. (2022). Identification of a novel recurrent EEF2 gene amplification in familial prostate tumors. Genes Chromosomes and Cancer. 62(5). 247–255. 1 indexed citations

Marthick, James R., et al.. (2022). Analysis of a large prostate cancer family identifies novel and recurrent gene fusion events providing evidence for inherited predisposition. The Prostate. 82(5). 540–550. 3 indexed citations

Blizzard, Christopher Leigh, et al.. (2022). Urban–rural prostate cancer disparities in a regional state of Australia. Scientific Reports. 12(1). 6 indexed citations

Siva, Shankar, Mathias Bressel, Tomas Kron, et al.. (2020). Stereotactic Ablative Fractionated Radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the Lung: A Randomized Phase II Trial. International Journal of Radiation Oncology*Biology*Physics. 108(3). S3–S4. 4 indexed citations

Kneebone, Andrew, Amy Hayden, David Christie, et al.. (2019). Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group. Radiotherapy and Oncology. 140. 68–75. 24 indexed citations

Taberlay, Phillippa C., Adele F. Holloway, Mark Ambrose, et al.. (2019). DNA methylation changes following DNA damage in prostate cancer cells. Epigenetics. 14(10). 989–1002. 19 indexed citations

Ball, David, Gang Mai, Shalini Vinod, et al.. (2018). Quality of life in the CHISEL randomized trial of stereotactic ablative radiotherapy (SABR) versus standard radiotherapy for stage I non-small cell lung cancer (Trans-Tasman Radiation Oncology Group 09.02). Annals of Oncology. 29. ix139–ix139. 1 indexed citations

Millar, Jeremy, Siddhartha Baxi, Martin Borg, et al.. (2018). Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method. Radiotherapy and Oncology. 128(2). 308–314. 13 indexed citations

Hayden, Amy, David Christie, Brian J. Davis, et al.. (2018). Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group. Radiotherapy and Oncology. 129(2). 377–386. 46 indexed citations

10.

Ball, Daniel, Shalini Vinod, Scott Babington, et al.. (2017). MA 13.07 A Randomized Trial of SABR vs Conventional Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: TROG09.02 (CHISEL). Journal of Thoracic Oncology. 12(11). S1853–S1853. 26 indexed citations

11.

Evans, Sue, Nupur Nag, David Roder, et al.. (2016). Development of an International Prostate Cancer Outcomes Registry. British Journal of Urology. 117(S4). 60–67. 31 indexed citations

12.

Foroudi, Farshad, Daniel Pham, Aldo Rolfo, et al.. (2014). The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART. Radiotherapy and Oncology. 111(2). 316–320. 37 indexed citations

13.

Young, Arabella, Adele F. Holloway, Nicholas B. Blackburn, et al.. (2014). RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization. BMC Cancer. 14(1). 808–808. 31 indexed citations

14.

Lehman, Margot, Mark Sidhom, Andrew Kneebone, et al.. (2013). FROGG high‐risk prostate cancer workshop: Patterns of practice and literature review. Part II post‐radical prostatectomy. Journal of Medical Imaging and Radiation Oncology. 58(3). 392–400. 4 indexed citations

15.

Turner, Sandra, Jeremy Millar, Farshad Foroudi, et al.. (2012). Australian & New Zealand Faculty of Radiation Oncology Genito‐Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder. Journal of Medical Imaging and Radiation Oncology. 56(1). 18–30. 12 indexed citations

16.

Vesprini, Danny, Charles Catton, Lindsay M. Jacks, et al.. (2011). Inverse Relationship Between Biochemical Outcome and Acute Toxicity After Image-Guided Radiotherapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 83(2). 608–616. 6 indexed citations

17.

Martin, Jarad, Andrew Kneebone, Margot Lehman, et al.. (2010). Australian & New Zealand Faculty of Radiation Oncology Genito‐Urinary Group: 2010 consensus guidelines for definitive external beam radiotherapy for prostate carcinoma. Journal of Medical Imaging and Radiation Oncology. 54(6). 513–525. 32 indexed citations

18.

Skala, Marketa, Tara Rosewall, Laura A. Dawson, et al.. (2007). Patient-Assessed Late Toxicity Rates and Principal Component Analysis After Image-Guided Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 68(3). 690–698. 46 indexed citations

19.

Skala, Marketa, Lois Holloway, Michael Bailey, & Andrew Kneebone. (2005). Australia‐wide comparison of intensity modulated radiation therapy prostate plans*. Australasian Radiology. 49(3). 222–229. 9 indexed citations

20.

Skala, Marketa, Martin Berry, Gillian Duchesne, et al.. (2004). Australian and New Zealand three‐dimensional conformal radiation therapy consensus guidelines for prostate cancer. Australasian Radiology. 48(4). 493–501. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact